oppn parties US Ban On Exporting Key Vaccine Ingredients: Not Right In The Times Of The Pandemic

News Snippets

  • SP drops two candidates owing allegiance to Azam Khan from Rampur and Moradabad
  • In Assam, a controversy erupted after a picture of UPPL leader Benjamin Basumatary, lying on a stack of Rs 500 notes circulated on social media. UPPL is an ally of the BJP
  • AAP's Jalandhar-West MP Sushil Kumar Rinku joins the BJP. He was the only AAP Lok Sabha MP
  • Supreme Court dismisses Centre's plea to review its 2023 verdict in the PMLA case
  • Close save for passengers as they remain unhurt after the wings of two planes graze at Kolkata airport. Pilots derostered and inquiry ordered by DGCA
  • Bengal BJP leader Dilip Ghosh gets notice from the EC as well as the BJP for making ugly remarks about Mamata Banerjee's parentage
  • Sadanand Vasanth Date, who faught terrorists in the 26/11 attack and was awarded the Preisent's Police medal, has been appointed the head of the NIA
  • Centre will borrow Rs 7.5L cr in the first six months of FY25, nearly 50% of the target for the full year
  • 25 stocks, including SBI, will see same day trade settlements from today in the world's fastest settlement mode in both BSE and NSE
  • Stocks recover smartly on Wednesday: Sensex rises 526 points to 72996 and Nifty 118 points to 22123
  • Tennis: Rohan Bopanna-Matthew Ebden reached the semifinals of the Miami Open
  • IPL: records tumble as SRH beat MI in a high-scoring match. SRH score 277/3 with 18 sixes and Mumbai score 246 with 20 sixes to fall short by 31 runs. Atotal of 38 sixes, highest in an IPL match were hit and both teams combined to score 523 runs, the highest aggregate in an IPL match
  • Amul will launch fresh milk in the US
  • IPL: RCB beat Punjab by 4 wickets as Kohli and Karthik shine with the bat
  • India strongly objected to German foreign office remarks over the arrest of delhi CM Arvind Kejriwal, called it "biased assumptions"
Delhi Lt Governor Vinai Kumar Saxena says government cannot be run from jail, hints at President's Rule in the capital ////// In a dangerous incident, the wings of two planes grazed while taxiing on the runway at Kolkata airport, all passengers were safe but DGCA ordered an inquiry and the pilots were derostered
oppn parties
US Ban On Exporting Key Vaccine Ingredients: Not Right In The Times Of The Pandemic

By A Special Correspondent
First publised on 2021-04-24 06:16:50

There is no disputing the fact that the US is the worst affected country in the Covid-19 pandemic. As on April 22, it had reported 32,735,704 cases with 585,075 deaths due to coronavirus. These are disturbing figures. But the Biden administration has brought things under control by rapidly vaccinating the US population. Till now, 35 percent of US citizens have been fully vaccinated and about 52 percent have received the first dose. These are excellent figures and will help the country win the war against the virus. Additionally, the US has ample stock of vaccines and more supplies are in the pipeline. At this rate, it will be able to fully vaccinate its entire population in a couple of months and will still be left with massive stocks. Is it ethical for the US to hold on to these doses or to restrict export of vital vaccine making ingredients so urgently required in countries like India on the plea of "Americans first"?

The US has activated the Defence Production Act (generally used in wartime to prevent the country from suffering shortages) to ban the export of key ingredients used in making Covid vaccines. The US company Novamax had contracted to supply these ingredients to Serum Institute of India, which produces the Oxford University-AstraZeneca vaccine Covishield. With India now in the grip of a severe second wave of infections, it vaccination drive runs the risk of getting derailed due to these US restrictions. But the US is in no mood to relent.

Although taking care of its own citizens must be the priority of the government of any country at all times, a spirit of constructive cooperation is expected at times when the entire humanity is threatened. India, despite its limitations, had contributed handsomely to the CoVax programme to make vaccines available to countries around the world, before putting restrictions to vaccinate its own people. But India’s case is obviously different. It has to vaccinate at least 85 crore people in the next six to eight months to achieve herd immunity. For this it needs 170 crore doses, at the rate of 28 crore or 21.25 crore doses per month. While India has taken steps to ramp up its production capacity, without key ingredients, it will be difficult to make the vaccines. Hence, the US must consider the situation and make an exception in India’s case. After all, the US needs just 64 crore doses to fully vaccinate its entire population (which is not possible because as of now, the vaccine has not been tried on children below 16 years of age)and much less to achieve herd immunity.